Roivant Sciences Ltd. Warrant (ROIVW)
$2.75
$-0.11
(-3.85%)
As on 01-Sep-2023 15:45EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Roivant Sciences Ltd. Warrant (ROIVW)
| 41.8 | -15.4 | 36.8 | 508.7 | -- | -- | -- |
|
BSE Sensex*
| -11.7 | -2.7 | -8.0 | -8.0 | 6.2 | 7.8 | 10.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Roivant Sciences Ltd. Warrant (ROIVW)
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases,... hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom. Read more
-
Headquarters
--
-
Website
--
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Roivant Sciences Ltd. Warrant (ROIVW)
What is the current share price of Roivant Sciences Ltd Warrant (ROIVW) Today?
The share price of Roivant Sciences Ltd Warrant (ROIVW) is $2.75 (NASDAQ) as of 01-Sep-2023 15:45 EDT. Roivant Sciences Ltd Warrant (ROIVW) has given a return of 508.68% in the last 1 years.
What is the current PB & PE ratio of Roivant Sciences Ltd Warrant (ROIVW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
-0.88
|
0.67
|
|
2022
|
-0.66
|
0.30
|
|
2021
|
-0.65
|
0.32
|
|
2023
|
-0.88
|
0.67
|
|
2022
|
-0.66
|
0.30
|
What is the 52 Week High and Low of Roivant Sciences Ltd Warrant (ROIVW)?
The 52-week high and low of Roivant Sciences Ltd Warrant (ROIVW) are Rs -- and Rs -- as of 31-May-2026.
What is the market cap of Roivant Sciences Ltd Warrant (ROIVW)?
Roivant Sciences Ltd Warrant (ROIVW) has a market capitalisation of -- as on 01-Sep-2023. As per SEBI classification, it is a company.
Should I invest in Roivant Sciences Ltd Warrant (ROIVW)?
Before investing in Roivant Sciences Ltd Warrant (ROIVW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.